Receipt of Medicare Part D comprehensive medication reviews in older adults with dementia [0.03%]
老年痴呆症患者接受医疗保险D部分全面药物审查的情况
Antoinette B Coe,Jonathan Martindale,Julie P W Bynum
Antoinette B Coe
Background: Older adults with Alzheimer disease and related dementias (ADRDs) are at high risk for medication-related problems. Comprehensive medication reviews (CMRs), required in Medicare Part D medication therapy manag...
Treatment patterns, health care resource utilization, and costs of chimeric antigen receptor T-cell vs standard therapy for relapsed/refractory mantle cell lymphoma in the United States [0.03%]
美国复发/难治性套细胞淋巴瘤的治疗模式、医疗资源利用和成本：嵌合抗原受体T细胞与标准疗法的比较
Karl M Kilgore,Philip K Chan,Christie Teigland et al.
Karl M Kilgore et al.
Background: Standard of care (SOC) for relapsed/refractory mantle cell lymphoma (R/R MCL) has included chemoimmunotherapy and targeted therapies (eg, Bruton tyrosine kinase inhibitors [BTKis]). The approval of novel chime...
Integrated health system pharmacy role in adherence, persistence, and adverse effect management for oral chronic lymphocytic leukemia therapy [0.03%]
综合健康系统药房在口服慢性淋巴细胞白血病治疗中的依从性、持续性和不良反应管理作用
Houston Wyatt,Stephanie White,Hannah Holloway et al.
Houston Wyatt et al.
Background: Oral oncolytic therapy for the management of chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL), such as ibrutinib, acalabrutinib, and venetoclax, have vastly changed CLL treatment. Althoug...
Bruce W Sherman,Brian Sils,Kimberly Westrich
Bruce W Sherman
As a major provider of health insurance for working-age Americans, employers can play a significant role in improving the health equity of their employees and family members. In this commentary, we describe how different stakeholders, inclu...
Correction [0.03%]
改正错误
Antidepressant adherence using group-based trajectory modeling among postpartum women with Texas Medicaid [0.03%]
德克萨斯州医疗保险产后妇女的抗抑郁药物依从性分组轨迹模型分析
Emma L Pennington,Jamie C Barner,Carolyn M Brown et al.
Emma L Pennington et al.
Background: Mental health conditions are among the most frequent underlying causes of pregnancy-related death, and antidepressants may have a positive impact. However, adherence is suboptimal, and little is known regardin...
Call for the alignment of Medicare Part D formularies with clinical treatment guidelines for asthma [0.03%]
呼吁将医疗保险药物清单与哮喘临床治疗指南对齐政策议案
Amelia Lao,Anusha McNamara,Lenny Lok Shun Chan et al.
Amelia Lao et al.
The Global Initiative for Asthma, the most widely cited international guidelines for asthma management, currently recommends the use of maintenance and reliever therapy with an inhaled corticosteroid-formoterol inhaler based on evidence sho...
Real-world treatment and health care utilization among patients with Duchenne muscular dystrophy by race and ethnicity in a Medicaid population [0.03%]
美国医疗补助项目中杜氏肌营养不良症患者的治疗及卫生保健利用情况——按种族和族裔分类
Nathaniel Posner,Janna Manjelievskaia,Anna K Talaga et al.
Nathaniel Posner et al.
Background: Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder, and data on the impact of patients' race on treatment outcomes and health care resource utilization are lacking. ...
Cost-effectiveness of cemiplimab plus chemotherapy vs pembrolizumab plus chemotherapy as first-line treatment for advanced non-small cell lung cancer [0.03%]
塞普利单抗联合化疗对比派姆单抗联合化疗作为晚期非小细胞肺癌一线治疗的卫生经济学效果分析
Xiangzhong Xue,Surachat Ngorsuraches,Brandon Johnson et al.
Xiangzhong Xue et al.
Background: In 2022, the US Food and Drug Administration approved cemiplimab in combination with chemotherapy (CCT) as a first-line treatment for advanced non-small cell lung cancer (aNSCLC). However, whether CCT presents...